The deadline moved. The responsibility didn’t.
- Ram Manda
- 2 hours ago
- 2 min read
DSCSA Exemption Extended: What Independent Pharmacies Need to Know
For independent pharmacies, the Drug Supply Chain Security Act (DSCSA) has created a significant operational challenge: implementing new requirements for tracking and securing prescription drugs while continuing to manage the day-to-day demands of running a pharmacy.
The FDA has now provided small dispensers with additional time.
The FDA Has Extended the Small Dispenser Exemption
The FDA is issuing exemptions from certain DSCSA requirements for small dispensers and, where applicable, their trading partners, through November 27, 2027.
This extension gives small pharmacies additional time to complete implementation of enhanced drug distribution security requirements.
What Does the Exemption Actually Mean?
This is where pharmacy owners need to pay attention.
The exemption applies to certain DSCSA requirements. It does not mean that small pharmacies are completely exempt from DSCSA.
The FDA continues to encourage small dispensers to work toward implementation of the enhanced drug distribution security requirements.
In other words:
The deadline has been extended. The work has not disappeared.
The additional time can be viewed as an opportunity for independent pharmacies to make sure their processes, technology and staff are ready before the requirements fully apply.
What Should Independent Pharmacies Do Now?
The additional year shouldn't be viewed as a reason to put DSCSA on the back burner.
Instead, pharmacy owners can use this time to get organized.
Confirm Whether Your Pharmacy Qualifies
Start by determining whether your organization meets the FDA's definition of a small dispenser.
The FDA states that the company owning the dispenser must have 25 or fewer full-time employees who are licensed pharmacists or qualified pharmacy technicians as of November 27, 2026.
Keep documentation supporting your determination.
Talk to Your Wholesalers and Trading Partners
Your pharmacy's DSCSA compliance doesn't happen in isolation.
Talk with your wholesalers and other applicable trading partners about:
· How transaction information will be exchanged
· What technology or platform they use
· What information your pharmacy needs to receive
· How discrepancies will be handled
· What happens when a product is identified as suspect or illegitimate
Understanding their processes now gives your pharmacy time to identify gaps.
Review Your Current Technology
Ask whether your pharmacy's existing systems can support the information and workflows required under DSCSA.
Don't wait until the deadline is approaching to discover that your current process requires significant changes.
Train Your Team
DSCSA isn't just an IT issue.
Your pharmacists and technicians need to understand what to do when something doesn't look right.
Your team should know how to recognize, quarantine, investigate and appropriately handle products that may be suspect or illegitimate, consistent with applicable requirements and your pharmacy's procedures.
Document Your Process
One of the most valuable things an independent pharmacy can do is create a clear, written process.
Document:
· Who is responsible for DSCSA activities
· How transaction information is received and maintained
· How suspect product concerns are escalated
· How products are quarantined
· Who communicates with wholesalers and other trading partners
· Where records are maintained
· How employees are trained
UPN is committed to keeping independent pharmacy owners informed about regulatory and industry changes that can affect the way they operate.
Read the FDA’s latest guidance on DSCSA exemptions: bit.ly/4wnCaAr
Take the Small Dispenser Assessment Survey: bit.ly/4fPmReW
Comments